NCT00630344View on ClinicalTrials.gov

RAD001 and Bicalutamide for Androgen Independent Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Prostate Cancer
Interventions
DRUG

RAD001

DRUG

Bicalutamide

Trial Locations (2)

02115

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER